SHLTN — SHL Telemedicine Cashflow Statement
0.000.00%
- CH₣24.18m
- CH₣23.06m
- $56.78m
- 28
- 55
- 19
- 21
Annual cashflow statement for SHL Telemedicine, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 0.278 | -13.9 | 0.215 | -6.86 | -27.8 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 0.203 | 14.9 | -3.68 | -1.09 | 17.6 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.727 | -6.45 | -3.74 | -1.24 | 2.25 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 4.68 | 0.185 | -0.073 | -1.5 | -0.372 |
Capital Expenditures | -1.77 | -3.26 | -6.9 | -5.49 | -3.66 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -5.88 | -37.7 | 0.471 | -3.85 | 9.7 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -7.65 | -41 | -6.43 | -9.35 | 6.03 |
Financing Cash Flow Items | — | — | -0.13 | -1.91 | -0.279 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.723 | 51.1 | -2.28 | 13.7 | -4.87 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1.93 | 10.7 | -10.4 | 2.21 | 0.986 |